Home > Pressrelease > Capnography Device Market worth over $873mn by 2027
Capnography Device Market worth over $873mn by 2027
- Published Date: September 13, 2021
Capnography Device Market size is set to exceed USD 873 million by 2027, according to a new research report by Global Market Insights Inc.
Growing technological advancements in capnography devices is among the key factors fueling the penetration of these products across the globe. The use of capnography devices for accurate and efficient airway management has surged due to the advent of novel techniques that play a vital role in the monitoring of respiratory function. Growing preference for minimally invasive procedures for respiratory disorders is expected to be one of the prominent factors driving the market growth globally. Furthermore, several market players have adopted a simplified and modern approach in terms of devices, thereby providing a safer and effective capnography instrument with optimum results.
Consistent rise in number of plastic surgeries are anticipated to promote the capnography device market expansion over the forecast period. As per the American Society of Plastic Surgeons (ASPS) statistics, in 2020, 13.2 million cosmetic minimally-invasive surgeries, 2.3 cosmetic surgical procedures, and 6.8 million reconstructive procedures were performed in the U.S. General anesthesia is commonly performed by the plastic surgeon to conduct these surgical procedures efficiently and capnography is an important part of the standard of care for all patients that receive general anesthesia
.
Numerous advantages offered by stand-alone capnography devices to stimulate the preference for these instruments
Get more details on this report - Request Free Sample PDF
The stand-alone segment in the capnography device market valued at USD 182 million in 2020 led by the high stability and improved directional & transposition functionality with minimum effort that helps the doctors to perform effective diagnostic assessments. The integration of an array of technologies with these devices has further assisted in improving patient monitoring with full accuracy, performance and reducing surgeons’ strain during lengthy & critical surgeries. Various controlling methods have been designed to provide both spot-check and bedside monitoring for capnography devices. Additionally, the commercialization of advanced hand-held capnography devices by prominent leaders will propel the segment growth.
Use of mainstream capnography in respiratory support and patients will promote the market progression
The mainstream segment captured 34% of the capnography device market share in 2020 impelled by the ability of mainstream capnography devices to offer several advantages that include measuring EtCO2 and FiCO2 concentration in the main stream breathing. Currently, the main stream capnography devices are gaining popularity primarily attributed to their surging application in patient monitoring, respiratory support, ventilation, and intensive care among others. Main stream capnography is invasive and non-diverting in nature, hence, delivers a real-time measurement of the carbon dioxide concentration. These devices are easy to connect & sterilize and can be used in collaboration with simultaneous oxygen administration through a nasal point.
Browse key industry insights spread across 250 pages with 288 market data tables & 19 figures & charts from the report, “Capnography Device Market Size By Product (Hand-held, Stand-alone, Multi-parameter), By Technology (Side Stream, Main Stream, Micro Stream), By Component (Original Equipment Manufacturer (OEM) Modules), By Application (Emergency Medicine, Critical Care, Procedural Sedation, Pain Management), By End-use (Hospitals, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/capnography-devices-market
Rising adoption of original equipment manufacturer (OEM) modules will accelerate the capnography device market value
The original equipment manufacturer (OEM) modules segment accounted for USD 234 million in 2020 propelled by the ability of these components to make carbon dioxide (CO2) or end-tidal carbon dioxide (EtCO2) monitoring simple and precise, even in portable and smaller monitors. Companies are emphasizing to meet OEM’s specification of capnography modules with special attention to compact designing, high efficiency with extended battery life, contamination free sampling, and longevity of devices. These components are easy to integrate and available in cost-effective & reliable side stream or mainstream versions for manufacturers.
Growing use of capnography technology in pain management to spur the market revenue
Capnography device market in the pain management segment will reach USD 144 million by 2027 owing to the requirement of monitoring respiratory rate & efficacy of ventilation during pain management. Capnography instruments are an ideal monitor for use during the administration of benzodiazepines and narcotics. The addition of EtCO2 monitoring allows earlier diagnosis of respiratory depression in this group of patients. Clinicians are widely using capnography instruments over pulse oximeters for post-operative pain management. Respiratory depression is a consistent effect of narcotic and opioid analgesics and may occur with therapeutic doses that require suitable monitoring throughout prehospital treatment and transport.
Several advantages provided by ambulatory surgical centers will influence the industry growth
The ambulatory surgical centers in the capnography device market crossed USD 166 million in 2020 due to the access to innovative medical technologies, affordable surgical procedures, etc. As per the Health Affairs article, the number of surgical procedures at ambulatory surgical centers has augmented significantly in the last few years. Additionally, majority of surgeries are performed in outpatient settings in the U.S. as ambulatory surgical centers offer an affordable alternative to hospitals for outpatient surgeries. On average, procedures performed in these healthcare facilities take approximately 31.8 minutes than surgeries performed in hospitals. Easy accessibility to a broad range of treatments with technologically advanced equipment caters to a considerable percent of the patient population undergoing numerous types of surgeries. As per the recently published report, these centers offer lower-risk surgeries in more appropriate settings at 35%-50% lower rates in comparison to hospitals, thereby boosting the revenue growth of the segment.
Rising prevalence of respiratory disorders in Germany will foster the industry expansion
Germany capnography device market size will account for USD 51 million by 2027 owing to the growing prevalence of respiratory disorders in the country. As per the European National Health and Wellness survey 2018, the prevalence of diagnosed asthma was around 5.9% in Germany. With the rising disease burden, the number of treatment procedures is also increasing that will drive the capnography instruments demand in the coming years.
Companies are focusing on strategies and launch of innovative products to expand customer base
Some of the major players operating in the market are Dragerwerk AG & CO. KGaA, Masimo Corporation, Medtronic, Nihon Kohden, Smiths Medical and Phillips Healthcare among others. These leaders are involved in partnerships, agreements, and acquisitions to gain an edge over their competitors.